This thread is for the discussion of and exchange of information on MRSA which is becoming more and more of an epidemic. Information on companies involved in the battle against MRSA is welcome and encouraged, but persistent hyping of a stock is not.
Some companies involved with MRSA (please help build the list):
Antibiotics:
Merck - investigating platensimycin, finance.yahoo.com
Theravence, Inc - investigational antibiotic telavancin finance.yahoo.com
Astellas Pharma, inc - telavancin (with Theravence) - astellas.us
Paratek Pharmaceuticals - investigational antibiotic PTK 0796 (with Merck), privately held paratekpharm.com
Targanta Therapeutics - investigational antibiotic oritavancin - IPO filed targanta.com
Other treatment:
Oculus - wound healing, finance.yahoo.com
Rapid Identification:
Cepheid - Xpert MRSA test (just over an hour) finance.yahoo.com
Acolyte Biomedica (owned by 3M) - BacLite Rapid MRSA (5 hours) acolytebiomedica.com
Accelr8 Technology - finance.yahoo.com
Here is some basic information provided from the CDC website:
Methicillin-resistant Staphylococcus Aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.
MRSA infections that are acquired by persons who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as CA-MRSA infections. Staph or MRSA infections in the community are usually manifested as skin infections, such as pimples and boils, and occur in otherwise healthy people.
cdc.gov
HA-MRSA - Healthcare Acquired MRSA
CA-MRSA - Community Acquired MRSA
VRSA - Vancomycin-resistant Staphylococcus aureus |
